Interactions of excitatory amino acid receptor antagonists with antiepileptic drugs in three basic models of experimental epilepsy.
Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 5
Abstract
Successful management of epilepsy still remains a vital problem. Despite using various combinations of antiepileptic drugs (AEDs), 20-25% of epileptic patients are insensitive to currently available medication. Therefore, there is a considerable need for finding a more effective AED or synergistic combinations of AEDs. Experimental and clinical data indicate that excitatory amino acid (EAA) receptor antagonists possess anticonvulsant potential. Moreover, EAA antagonists can potentiate the protective action of conventional AEDs. Unfortunately, not all beneficial (in terms of anticonvulsant activity) combinations may be recommended since some of them produce significant adverse effects which restrict their clinical use. The aim of this review was to assemble current literature data on interactions of EAA receptor antagonists with conventional AEDs. Generally, N-methyl-D-aspartate (NMDA) receptor antagonists combined with AEDs produce significant adverse effects. Non-NMDA receptor antagonists represent a more promising group.
Authors and Affiliations
Katarzyna Wojtal, Kinga Borowicz, Barbara Błaszczyk, Stanisław Czuczwar
Keywords
Related Articles
- EP ID EP128820
- DOI -
- Views 92
- Downloads 0
Influence of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of 4 classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Background: The aim of this study was to determine the effects of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione (TP10) on the protective action of 4 classical antiepileptic drugs - carbamaz...
Analgesia and serum assays of controlled-release dihydrocodeine and metabolites in cancer patients with pain.
Aim of the study was to assess dihydrocodeine (DHC) and metabolites concentrations and their correlations with DHC analgesia in cancer patients with pain. Thirty opioid-naive patients with nociceptive pain intensity asse...
Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients.
KYNA, an antagonist of ionotropic glutamate receptors and alpha7 nicotinic receptors, has been found as well in the brain as in the periphery. The altered metabolism of KYNA, especially its deficiency, can lead to the en...
Mitochondria and vascular pathology.
Functional and structural changes in mitochondria are caused by the opening of the mitochondrial permeability transition pore (PTP) and by the mitochondrial generation of reactive oxygen species (ROS). These two processe...
Influence of the antagonist of the glycine site of NMDA receptors, MRZ 2/576, on the anticonvulsant activity of conventional antiepileptic drugs in mice.
The purpose of this study was to evaluate the influence of the glycine site antagonist of the NMDA receptor, MRZ 2/576 (8-chloro-4-hydroxy-1-oxo-1,2-dihydropyridazino[4,5-b]quinolin-5-oxide choline salt), on the anticonv...